BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11722693)

  • 1. Screening mammography for frail older women: what are the burdens?
    Walter LC; Eng C; Covinsky KE
    J Gen Intern Med; 2001 Nov; 16(11):779-84. PubMed ID: 11722693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weighing the benefits and burdens of mammography screening among women age 80 years or older.
    Schonberg MA; Silliman RA; Marcantonio ER
    J Clin Oncol; 2009 Apr; 27(11):1774-80. PubMed ID: 19255318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing women's anxieties after abnormal mammograms: a controlled trial.
    Barton MB; Morley DS; Moore S; Allen JD; Kleinman KP; Emmons KM; Fletcher SW
    J Natl Cancer Inst; 2004 Apr; 96(7):529-38. PubMed ID: 15069115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year risk of false positive screening mammograms and clinical breast examinations.
    Elmore JG; Barton MB; Moceri VM; Polk S; Arena PJ; Fletcher SW
    N Engl J Med; 1998 Apr; 338(16):1089-96. PubMed ID: 9545356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: the long-term effects of false-positive mammograms.
    Brewer NT; Salz T; Lillie SE
    Ann Intern Med; 2007 Apr; 146(7):502-10. PubMed ID: 17404352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological consequences of false-positive screening mammograms in the UK.
    Bond M; Pavey T; Welch K; Cooper C; Garside R; Dean S; Hyde CJ
    Evid Based Med; 2013 Apr; 18(2):54-61. PubMed ID: 22859786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
    Burman ML; Taplin SH; Herta DF; Elmore JG
    Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
    Duijm LE; Groenewoud JH; Fracheboud J; de Koning HJ
    J Natl Cancer Inst; 2007 Aug; 99(15):1162-70. PubMed ID: 17652282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the cumulative risk of false-positive mammograms.
    Christiansen CL; Wang F; Barton MB; Kreuter W; Elmore JG; Gelfand AE; Fletcher SW
    J Natl Cancer Inst; 2000 Oct; 92(20):1657-66. PubMed ID: 11036111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits.
    Barton MB; Moore S; Polk S; Shtatland E; Elmore JG; Fletcher SW
    J Gen Intern Med; 2001 Mar; 16(3):150-6. PubMed ID: 11318909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
    Brett J; Austoker J
    J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the psychological consequences of false-positive screening mammograms.
    Bond M; Pavey T; Welch K; Cooper C; Garside R; Dean S; Hyde C
    Health Technol Assess; 2013 Mar; 17(13):1-170, v-vi. PubMed ID: 23540978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
    Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International variation in screening mammography interpretations in community-based programs.
    Elmore JG; Nakano CY; Koepsell TD; Desnick LM; D'Orsi CJ; Ransohoff DF
    J Natl Cancer Inst; 2003 Sep; 95(18):1384-93. PubMed ID: 13130114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening mammography in older women: a review.
    Walter LC; Schonberg MA
    JAMA; 2014 Apr; 311(13):1336-47. PubMed ID: 24691609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.